Wall Street’s Key Stock Analysts Research Report, All Buys

Wall Street’s Key Stock Analysts Research Report, All Buys

$CRL, $CVLT, $CVA, $DG, $FATE, $JD, $KR, $WMT

These are all Buys if you can manage the risk.

Daily HeffX-LTN reviews dozens of Wall Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. These reports cover stocks to buy

Below is our list for Thursday, 14 May, as follows:

Charles River Laboratories International Inc. (NYSE:CRL) was raised to Buy from Neutral at UBS.

CommVault Systems Inc. (NASDAQ:CVLT) was maintained as Buy but the price target was lowered to 53 from 55 at Needham.

Covanta Holding Corp. (NYSE:CVA) was raised to Buy from Neutral at UBS.

Dollar General Corp. (NYSE:DG) was reiterated as Buy and its price target was raised to 220 from 200 at BofA Securities.

Fate Therapeutics Inc. (NASDAQ:FATE) was started with a Buy rating and a 42 price target at HC Wainwright.

JD.com Inc. (NASDAQ:JD) was raised to Buy from Neutral and its price target was raised to 58 from 37 at Mizuho. The stock closed at 47.03 ahead of the call and had a 49.60 consensus price target.

Kroger Co. (NYSE:KR) was reiterated as Buy and its price target was raised to 42 from 37 at BofA Securities.

Target Corp. (NYSE:TGT) was reiterated as Buy and its price objective was raised to 145 from 125 at BofA Securities. Target had a 121.76 consensus price target.

Walmart Inc. (NYSE:WMT) was reiterated as Buy and its price objective was raised to 145 from 140 at BofA Securities. Walmart closed Wednesday at 123.71 with a 128.56 consensus price target.

Have a healthy day, Keep the Faith!

The following two tabs change content below.

Paul Ebeling

Paul A. Ebeling, a polymath, excels, in diverse fields of knowledge. Pattern Recognition Analysis in Equities, Commodities and Foreign Exchange, and he it the author of "The Red Roadmaster's Technical Report on the US Major Market Indices, a highly regarded, weekly financial market commentary. He is a philosopher, issuing insights on a wide range of subjects to over a million cohorts. An international audience of opinion makers, business leaders, and global organizations recognize Ebeling as an expert.